CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...